Alimera Sciences, Inc. (ALIM) was a big mover last session, as its shares rose nearly 63% on the day. This continues the recent uptrend for the company as the stock is now up almost 113% in the past one-month time frame.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Alimera currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some other medical stocks worth considering include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All these companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment